Illumina has announced its Extended RAS Panel, an FDA-approved next-generation sequencing (NGS) kit. [ + ]

Monash University scientists have published the results of their study into mesenchymal stem cells (MSCs) from Cynata Therapeutics, revealing that the company's technology holds promise as a treatment for chronic asthma. [ + ]

A personal cancer treatment vaccine that targets distinctive 'neoantigens' on tumour cells has been shown to stimulate a potent, safe and highly specific immune anti-tumour response in melanoma patients, reported scientists from Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. [ + ]

The life sciences industry has welcomed the restoration of key occupations for the medical technology, biotechnology, research and pharmaceutical sector to the skilled migration visa list. [ + ]

Cancer scientists have been found to overestimate the extent to which high-profile preclinical studies can be successfully replicated, in a study that follows numerous reports exploring biomedicine's so-called reproducibility crisis. [ + ]

LeafCann Group, a Melbourne-based medical cannabis producer, has formed a joint venture with Canadian developer of medical cannabis delivery systems and devices Resolve Digital Health. [ + ]

Arthur Sinodinos has announced the first 30 Superstars of STEM — an initiative to raise the profile of Australia's most dynamic female scientists and technologists and create a critical mass of strong, visible, relatable and public female role models in STEM. [ + ]

Despite being largely preventable, skin cancer costs Victoria's public hospitals more than $50 million a year, new research from Deakin University and Cancer Council Victoria has found. [ + ]

University of Queensland physicists are applying quantum physics to single molecule sensing for the first time, creating the possibility of detecting cancer at its earliest stages. [ + ]

Fujitsu Laboratories has developed a technology to retrieve similar disease cases from a computed tomography (CT) database of previously taken images. [ + ]

Radvax, a cancer treatment vaccine, being developed by South Australian company Vaxine, is closer to human trials. [ + ]

UK researchers are taking part in a £1.5 million study aiming to antibiotic resistance in sepsis patients — the largest ever trial to look at biomarkers in the blood to see whether antibiotics should be continued or can be safely stopped. [ + ]

Innate Immunotherapeutics has reluctantly announced that its MS therapy MIS416 showed no meaningful or statistically significant results in a recent Phase 2B trial, with the company's shares dropping a whopping 92% as a result. [ + ]

Australian listed companies Monash IVF and RHS (Reproductive Health Science) have partnered to develop an accurate way to test for chromosome number in embryos without biopsy. [ + ]

Miele is set to acquire a controlling stake in the Steelco Group to further expand in the medical technology industry. [ + ]